The clinical approach to managing Bacillus anthracis infections is undergoing a critical phase of modernization, driven by increased biodefense stockpiling and advancements in antitoxin research. The Anthrax Treatment Market was valued at USD 483.34 million in 2024 and is expected to reach USD 800.57 million by 2032, expanding at a CAGR of...